
Loading, please wait...

Loading, please wait...

Scientists recently investigated the protective potential of dipicolinic acid (DPA) against diclofenac-induced myocardial injury. Specifically, this study focuses on how DPA regulates the glutathione-dependent antioxidant system. It also reduces programmed cell death in heart tissue. By utilizing male laboratory rats, researchers evaluated different doses of DPA under pathological conditions. Therefore, the results demonstrate that DPA significantly lowers cardiac damage markers. In addition, it improves the physical structure of the heart.
Furthermore, the compound helps normalize levels of essential molecules like α-tocopherol and glutathione. It also boosts the activity of key antioxidant enzymes. Specifically, researchers noted improvements in glutathione peroxidase and transferase functions. However, these enzymes must function correctly to neutralize harmful free radicals that damage heart cells. Consequently, DPA acts as a vital mediator in this protective process.
Additionally, DPA influences the supply of NADPH by regulating specific dehydrogenases like glucose-6-phosphate dehydrogenase. Therefore, this metabolic enhancement provides the necessary fuel for antioxidant reactions. Moreover, the study highlights a significant reduction in apoptosis. Specifically, DPA effectively inhibits the activity of inductor and effector caspases such as caspase-8 and caspase-3. Although it did not affect the apoptosis-inducing factor, the overall reduction in cell death signaling remains notable.
Consequently, these improvements suggest that DPA enhances myocardial metabolism significantly. In addition, the substance exhibits an antithrombotic effect. By inhibiting free radical-mediated oxidation, DPA serves as a powerful shield for biological molecules. Similarly, these findings provide a promising foundation for future clinical applications in managing NSAID-related cardiotoxicity.
DPA protects the heart by regulating the glutathione-dependent antioxidant system and reducing the activity of caspases involved in apoptosis. It helps maintain the balance of essential antioxidants.
In animal studies, DPA administration led to a reduction in cardiac damage markers and improved the morphology of heart tissue following injury.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Kryl'skii E et al. Dipicolinic Acid Exerts a Cardioprotective Effect Through Its Regulation of the Functioning of the Glutathione-Dependent Antioxidant System and Apoptosis in Diclofenac-Induced Myocardial Injury. J Appl Toxicol. 2026 Mar 13. doi: 10.1002/jat.70144. PMID: 41826251.
Ghosh R, et al. NSAID-induced cardiotoxicity: Mechanisms and protective strategies. International Journal of Cardiology. 2023.
National Center for Biotechnology Information. Glutathione and Myocardial Ischemia-Reperfusion Injury. PubChem Database. 2024.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study explores how Dipicolinic Acid mitigates diclofenac-induced myocardial injury by regulating glutathione-dependent antioxidants and reducing apoptosis...
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today